Marizyme, Inc. (MRZM)
Develops enzymes and medical devices for heart surgery, wound care, and disease screening.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
MRZM is trading at its 52-week low with minimal price movement today. The stock sits above both its 50- and 200-day moving averages, suggesting some near-term support, though the overall outlook registers as neutral. At this micro-cap price level, liquidity and analyst coverage are likely sparse.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$39,537
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—